Switzerland is known internationally for its longstanding experience in harm reduction, including pioneering programs for opioid-dependent people. Content on this tag covers Switzerland’s drug policy approaches, visits by Swiss healthcare professionals to Barcelona’s cannabis social clubs, and the country’s emerging regulatory frameworks for psychedelic-assisted therapies in clinical contexts.
